Aller au contenu principal
Profil bibliographique

Alexander S. Rusanov

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

11Publications signalées
95Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Angiogenesis and VEGF in CancerCancer, Hypoxia, and MetabolismCancer, Lipids, and MetabolismHepatocellular Carcinoma Treatment and PrognosisMicroRNA in disease regulation

Les publications récentes

2026 article OpenAlex

The Thorny Question of Early Diagnosis in Lung Cancer: Should the IP-10 Cytokine be Brought to Trial?

Yvan Sinclair Ngaha Tchawe, Freddy Elad Essogmo, Ikenna Kingsley Uchendu, Abah Moses Owoicho et autres

BACKGROUND: Lung cancer remains the leading cause of cancer mortality worldwide, underscoring the need for non-invasive early diagnostic tools. IP-10, a cytokine involved in inflammation and angiogenesis, is a promising candidate. The present study aims to assess the relevance of IP-10 in …

ru (code pays fourni par la source)

0 citations Current Cancer Drug Targets
Accès ouvert 2023 article OpenAlex

Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines

Freddy Elad Essogmo, Angelina V. Zhilenkova, Yvan Sinclair Ngaha Tchawe, Abah Moses Owoicho et autres

Lung cancer is currently the second leading cause of cancer death worldwide. In recent years, checkpoint inhibitor immunotherapy (ICI) has emerged as a new treatment. A better understanding of the tumor microenvironment (TMJ) or the immune system surrounding the tumor is needed. …

ru, Cameroun (code pays fourni par la source)

28 citations Cancers
Accès ouvert 2023 preprint OpenAlex

Epidemiology Patterns of Renal Cell Carcinoma Worldwide: Examining Risk Factors and Contemporary Immunotherapy Approaches

Ikenna Kingsley Uchendu, Yvan Sinclair Ngaha Tchawe, Zhilenkova Angelina V., Zaiana D. Sangadzhieva et autres

Renal cell carcinoma (RCC), alternative term for kidney cancer, is becoming more common worldwide each year, and there are many different contributing factors. Among all cancers, RCC is the 14th most prevalent; and it ranks as the 14th and 9th most prevalent …

Nigéria, ru, nl (code pays fourni par la source)

4 citations Preprints.org
Accès ouvert 2023 article OpenAlex

Angiogenesis in Lung Cancer: Understanding the Roles of Growth Factors

Angelina V. Zhilenkova, Freddy Elad Essogmo, Ikenna Kingsley Uchendu, Abah Moses Owoicho et autres

Research has shown the role of growth factors in lung cancer angiogenesis. Angiogenesis promotes lung cancer progression by stimulating tumor growth, enhancing tumor invasion, contributing to metastasis, and modifying immune system responses within the tumor microenvironment. As a result, new treatment techniques …

ru, ch, Nigéria, Cameroun (code pays fourni par la source)

54 citations Cancers
Accès ouvert 2023 preprint OpenAlex

Angiogenesis in Lung Cancer: Understanding the Roles of Growth Factors

Yvan Sinclair Ngaha Tchawe, Zhilenkova Angelina V., Ikenna Kingsley Uchendu, Abah Moses Owoicho et autres

Research has shown the role of growth factors in lung cancer angiogenesis. Angiogenesis promotes lung cancer progression by stimulating tumor growth, enhancing tumor invasion, contributing to metastasis, and modifying immune system responses within the tumor microenvironment. As a result, new treatment techniques …

ru, nl, ch, Nigéria, Cameroun (code pays fourni par la source)

1 citation Preprints.org
Accès ouvert 2023 preprint OpenAlex

Angiogenesis in Lung Cancer: Understanding the Roles of Growth Factors

Yvan Sinclair Ngaha Tchawe, Zhilenkova Angelina V., Ikenna Kingsley Uchendu, Abah Moses Owoicho et autres

Research has shown the role of growth factors in lung cancer angiogenesis. Angiogenesis promotes lung cancer progression by stimulating tumor growth, enhancing tumor invasion, contributing to metastasis, and modifying immune system responses within the tumor microenvironment. As a result, new treatment techniques …

ru, nl, ch, Nigéria, Cameroun (code pays fourni par la source)

2 citations Preprints.org
Accès ouvert 2023 preprint OpenAlex

Cytokine Profile in Lung Cancer Patients: Anti-tumor and Oncogenic Cytokines

Freddy Elad Essogmo, Zhilenkova Angelina V., Abah Moses Owoicho, Yvan Sinclair Ngaha Tchawe et autres

Lung cancer accounts for the majority of cancer cases. In recent years, checkpoint inhibitor immunotherapy (ICI) has emerged as a new treatment. A better understanding of the tumor microenvironment, or TMJ, or the immune system surrounding the tumor is needed. Cytokines are …

ru, nl (code pays fourni par la source)

2 citations Preprints.org
Accès ouvert 2013 conference-abstract OpenAlex

P-216REDUCING THE EXTENT OF RESECTION IN NON-SMALL CELL LUNG CANСER WITH THE USE OF PHOTODYNAMIC THERAPY

А. Л. Акопов, Alexander S. Rusanov, Ivan Chistyakov, Nikita Kazakov et autres

About one-third of NSCLC patients have unresectable locally advanced tumour or limited pulmonary function. Preoperative and intraoperative photodynamic therapy (PDT) was performed for the purpose of reducing the extent of resection in this type of patients. Twenty-two patients with central stage II-III …

ru (code pays fourni par la source)

1 citation Interactive Cardiovascular and Thoracic Surgery
2011 conference-abstract OpenAlex

Poster Session 3

Giulia Fabbri, Samuele Baldasseroni, Domenico Panuccio, Massimo Zoni Berisso et autres

Results: Out of 664159 women there were 22938 patients with hyperlipidaemia (3.5%) and 9312 patients with breast cancer. Out of the hyperlipidaemia patients, 530 patients developed breast cancer (2.3%) compared with 8782 patients developing breast cancer without hyperlipidaemia (1.4%). A logistic regression …

3 citations EP Europace

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.